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Abstract
Background: The majority of mental health problems are non-psychotic (e.g., depression, anxiety, and phobias). For
some people, art therapy may be a more acceptable alternative form of psychological therapy than standard forms
of treatment, such as talking therapies. This study was part of a health technology assessment commissioned by
the National Institute for Health Research, UK and aimed to systematically appraise the clinical and cost-effective
evidence for art therapy for people with non-psychotic mental health disorders.
Methods: Comprehensive literature searches for studies examining art therapy in populations with non-psychotic
mental health disorders were performed in May 2013. A quantitative systematic review of clinical effectiveness and
a systematic review of studies evaluating the cost-effectiveness of group art therapy were conducted.
Results: Eleven randomised controlled trials were included (533 patients). Meta-analysis was not possible due to
clinical heterogeneity and insufficient comparable data on outcome measures across studies. The control groups
varied between studies but included: no treatment/wait-list, attention placebo controls and psychological therapy
comparators. Art therapy was associated with significant positive changes relative to the control group in mental
health symptoms in 7 of the 11 studies. A de novo model was constructed and populated with data identified from
the clinical review. Scenario analyses were conducted allowing comparisons of group art therapy with wait-list
control and group art therapy with group verbal therapy. Group art-therapy appeared cost-effective compared with
wait-list control with high certainty although generalisability to the target population was unclear; group verbal
therapy appeared more cost-effective than art therapy but there was considerable uncertainty and a sizeable
probability that art therapy was more cost effective.
Conclusions: From the limited available evidence art therapy was associated with positive effects compared with
control in a number of studies in patients with different clinical profiles. The included trials were generally of poor
quality and are therefore likely to be at high risk of bias. Art therapy appeared to be cost-effective versus wait-list
but further studies are needed to confirm this finding in the target population. There was insufficient evidence to
make an informed comparison of the cost-effectiveness of group art therapy with group verbal therapy.
Trial registration: HTA project no. 12/27/16; PROSPERO registration no. CRD42013003957.
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Background
Mental ill health is recognised as the largest cause of
disability in the United Kingdom [1]. The UK Depart-
ment of Health have prioritised making mental health
services more effective and accessible in response to
evidence that such services are not meeting the needs
of some groups of people [2, 3]. The majority of mental
health problems are non-psychotic (e.g., depression,
anxiety, and phobias). For some people with these con-
ditions, art therapy may be an acceptable alternative
form of psychological therapy than more standard
forms of treatment, such as talking therapies [4]. For
example, for those who find it difficult to express them-
selves in verbal language alone as required by more
standard forms of treatment for mental health prob-
lems, arts therapies can provide an alternative means of
expression to help service users understand, make
sense of, and cope with their distress. There is some
published evidence to support the claim that art
therapy is effective in treating a variety of symptoms
and disorders in patients of different ages [5, 6]. How-
ever, to date a full systematic review of the clinical
and cost-effectiveness of art therapy for non-psychotic
mental disorders had not been undertaken. This pro-
ject aimed to systematically review the current clinical
and cost-effectiveness evidence for art therapy for
people with non-psychotic mental disorders. In ad-
dition, a de novo cost-effectiveness analysis would be
undertaken if the systematic review did not identify
suitable studies.
Art therapy is a specific branch of treatment under
the umbrella term “arts therapies” used by the Health
Care Professions Council (HCPC) which includes drama
therapy and music therapy. For the purpose of this
review these other forms of arts therapies, which do
not centre on the creation of a sustainable, physical
piece of visual art, are excluded. Despite art therapy
being an established and practised form of psycho-
logical therapy for decades, only more recently have
researchers in the field of art therapy addressed the need
to integrate art therapy into a model of evidence-based
practise. Therefore, an abundance of literature exists
consisting of single case studies or theoretical concepts
in art therapy [7]. This study was part of a health technol-
ogy assessment commissioned by the National Institute
for Health Research, UK and aimed to systematically
assess:
a) What is the evidence that art therapy is
clinically effective in people with non-psychotic
mental health disorders?
b) What is the evidence that art therapy is
cost-effective in people with non-psychotic
mental health disorders?
Methods
Search methods
Comprehensive literature searches were used to inform
the clinical and cost-effectiveness reviews. A search
strategy was developed to identify reviews, randomised
controlled trials (RCTs), economic evaluations and all
other study types relating to art therapy. Search terms
were restricted to “art therapy” or “art therap$”. Metho-
dological search filters were applied where appropriate.
No other search limitations were used and all databases
were searched from inception to present. Searches were
conducted from May–July 2013.
Databases searched were: MEDLINE and MEDLINE
in Process & Other Non-Indexed citations; EMBASE;
Cochrane Library; Science Citation Index; Social Sciences
Citation Index; CINAHL: Cumulative Index to Nursing
and Allied Health Literature; PsycINFO; AMED: Allied
and Complementary Medicine; and ASSIA: Applied Social
Sciences Index and Abstracts. All resources were searched
from inception to present.
Clinical effectiveness review methods
Screening of records, study selection, and data extrac-
tion were performed by one assessor and checked by a
second assessor. All studies identified for inclusion
at abstract stage were obtained in full text for more
detailed appraisal. Non-English studies were translated
and included if relevant. Quality assessment of included
studies was performed independently by two reviewers
using quality assessment criteria adapted from the
Cochrane risk of bias, CRD guidance, and CASP check-
lists to develop a modified tool to allow comprehensive
and relevant quality assessment for the included trials.
The inclusion and exclusion criteria for the clinical ef-
fectiveness review are documented in Table 1.
Mathematical modelling methods
A de novo mathematical model was constructed. Due to
the nature of the study question it was deemed that a
complex model was not required, and that a simple
model which could more clearly demonstrate the impact
of key drivers of the cost effectiveness ratio would be
sufficient. As such, an area under the curve model was
developed to estimate the gain in utility with the follow-
ing assumptions in the base case.
1. That the maximum treatment effect would be
associated with the time at which treatment ended.
2. That there would be a linear increase in treatment
effect, from zero at baseline to the maximum at the
time at which treatment ended.
3. That there would be a residual effect of treatment
with a linear decline in benefit until there was zero
benefit at 52 weeks.
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4. That given the short assumed duration of benefit,
discounting of future costs and benefits was not
necessary.
The rationale for choosing 52 weeks as the base case
duration of residual benefit was based on a number of
relevant references. Discussing data in Nicholson and
Berman [8] and in Lambert and Ogles [9], Cooper wrote
that ‘findings from the empirical research are fairly clear:
clients, on average, do not tend to improve once their
therapy is over...., but equally they do not tend to deterior-
ate rapidly’ [10]. More recent data provided in Sportel et
al. [11], indicate that where Cognitive Bias Modification
and Cognitive Behavioural Group Training provided lar-
ger decreases in an outcome measure (the Spielberger
Test Anxiety Inventory) [12] the effect had not entirely
waned at twelve month follow-up. This may be generalis-
able to other forms of successful psychological therapy,
and conservatively we elected to assume that all benefit
had dissipated at 52 weeks post treatment, although a lon-
ger period of 104 weeks was used in sensitivity analyses.
The conceptual model used to calculate the utility gain
across time is shown in graphical form in Fig. 1. In this
figure it is assumed that there is a gain in utility of
0.0780 at week 8. The area under the curve was then
translated in quality adjusted life years (QALYs) assum-
ing 52.18 weeks per year. The QALY considers both
duration and quality of life: a person living 10 years at a
utility of 0.5 would accrue 5.0 undiscounted QALYs
whilst a person living 8 years with a utility of 0.8 would
accrue 6.4 undiscounted QALYs.
Results and discussion
The total number of published articles yielded from elec-
tronic database searches after duplicates were removed
was 10,073. An additional 197 records were identified
from supplementary searches, resulting in a total of
10,270 records for screening. Of these, 10,221 records
were excluded at title/abstract screening. Figure 2 shows
the flow of studies identified and included in the review.
Clinical effectiveness results and discussion
Eleven RCTs of group art therapy were included in the
clinical effectiveness review. Eight of the studies were
conducted in adults and three were conducted in chil-
dren. All trials had small final sample sizes with the
number of participants reported to be included in each
study ranging between 18 and 111. The total number of
patients in the included studies is 533.
Table 1 Inclusion and exclusion criteria for the systematic review
Included Excluded
Population Non-psychotic clinical
samples
People with psychosis
Healthy samples
Intervention aGroup art therapy as might
be delivered in the NHS
Other “arts therapies”
including drama; music;
and dance
Play therapy
Comparator Any including: interventions
including an RCT containing
art therapy; treatment as
usual; waiting list; attention
placebo; or other
psychological therapy
None
Outcomes Primary: treatment
effectiveness; response as
determined by changes in
mental health rating scales;
Outcomes focussed on
interpretation of the art
work itself, not the
participant
Secondary: Related clinical
or quality of life outcomes
Studies Randomised controlled trials Non-randomised
controlled studies
aWhilst the full health technology assessment (Uttley et al., in press) included
studies of both individual and group art therapy, only studies of group art
therapy are included in this paper
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Fig. 1 An illustration of the conceptual model of utility
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As can be seen from Table 2 eight studies compared
art therapy with an active control group. The compara-
tor groups from the included studies can be seen in
Fig. 3. Two of the studies were versus a psychological
therapy (Broome [13] & Thyme [14]) whereas six studies
were attention placebo control groups which mimic the
amount of time and attention the intervention group
receives. Three studies compared art therapy with a
wait-list control or treatment as usual. The majority of
studies were conducted in a community/outpatient set-
ting, but the precise setting location for conducting the
intervention was not reported in four studies (Broome
[13]; Kim [15]; Monti [16]; Monti [17]) and one study
was reported to be conducted in an outpatient setting
(Lyshak-Stelzer et al. [18]).
The symptoms or ‘outcome domains’ under investiga-
tion and associated outcome measures are reported in
Table 3.
The study populations were heterogeneous in their
clinical profiles highlighting the wide application of art
therapy but also demonstrating the difficulty in obtain-
ing a pooled estimate of treatment effect. The control
groups across the included studies are heterogeneous
therefore there may be different estimates of treatment
effects depending on what art therapy is compared
against. Additionally, despite common mental health
symptoms being investigated across the included RCTs,
the majority of studies were using different measure-
ment scales to assess these outcomes (see Table 3).
Therefore as there is insufficient comparable data on
outcome measure across studies it is not possible to per-
form a formal pooled analysis.
Potential treatment effect modifiers include the experi-
ence/qualification of the art therapist, characteristics
that were not consistently reported. Also, the age of the
included patients could be a potential effect modifier as
eight studies are of adults and three are of children. Pre-
existing physical conditions were present in seven of the
included studies which could also represent a potential
treatment effect modifier.
The direction of statistically significant results from
the 15 included RCTs are summarised in Table 4.
As can be seen in Table 4, in 10 of the 11 included
studies there were improvements from baseline in some
outcomes in the art therapy groups. However, both the
intervention and the control groups improved from
baseline in three studies with no significant difference
between the groups (Broome [13]; McCaffrey [19] and
Fig. 2 A modified PRISMA flow diagram of the studies identified and included in the clinical effectiveness review
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Table 2 Characteristics of the included studies of art therapy
Study author & year Country Number Patients Art therapy description Control description
Beebe et al. 2010 [29] USA 22 Children with asthma Included an opening activity;
discussion of the weekly topic
and art intervention; art making;
opportunity for the parents to
share their feelings related to the
art they created, and the closing
activity.
Wait-list
Broome et al. 2001 [13] USA 97a Children (n = 65); & adolescents
(n = 32) with sickle cell disease
Opportunity to express feelings
about pain and develop social
skills through interactions with
others using art as a focal point
for their disease and ethnicity
Cognitive Behavioural Therapy
“Relaxation” for pain or; Attention
control (fun activities e.g. picnic,
museum) for children group only
Gussak 2007 [30] USA 44a Incarcerated males Asked to draw person picking
an apple from a tree and other
similar art therapy tasks
No treatment
Hattori et al. 2011 [24] Japan 39 Adults with alzheimer’s disease Primary task to colour abstract
patterns which are unclear
before colouring. Encouraged to
draw familiar objects based on
memories or favourite seasons
Simple calculations (additions
and multiplications of 1 or 2
figure numbers). No pre-set
target; patients completed as
many as could in session
Kim 2013 [15] Korea 50 Non-clinical older adults Introductory 10–15 min
‘unfreezing’ phase, followed by
35–40 min for individual art
making, 15–20 min for group
discussion
Regular programme activities
such as reading books, playing
board games, and watching
television
Lyshak-Stelzer et al.
2007 [18]
USA 29 Adolescents with post-traumatic
stress disorder
Completion of at least 13
collages or drawings to express a
“life story” narrative. Encouraged
but not required to discuss
dreams, memories and feelings
related to their trauma
“Treatment as usual”–arts and
craft making activity group
McCaffrey et al.
2011 [19]b
USA 39 Older adults Drawing self-portraits; presented
to group; create new drawings;
display and discuss. (Art therapy
was reported as the control)
The two “intervention” groups
were individual (n = 13) or
guided (n = 13) garden walking
in the Morikami Museum and
Japanese Gardens in Delray
Beach
Monti et al. 2004 [31] USA 111a Women with cancer Mindfulness based art therapy
multi-modal programme
including a standardised
mindfulness-based stress reduc-
tion curriculum; art
therapy tasks and supportive
group therapy
Wait-list
Monti et al. 2006 [16]
Monti et al. 2012 [17] USA 18 Breast cancer (no clinical
mental health problem)
Mindfulness based art therapy.
Art making paired with
meditation and ways of
expressing emotional information
in a personally meaningful
manner
Educational support group:
control given equal time and
provided with support and
resources to maximise quality of
life including expert speakers on
topics and time for sharing and
supportive exchanges
Rusted et al. 2006 [20] UK 45a Adults with dementia Group-interactive psychodynamic
approach
Activity groups: a selection of
recreational activities from
different centres in the locality
Thyme et al. 2007 [14] Sweden 39 Depressed female adults Psychodynamic art therapy.
Painting and reflective dialogue
between the participant and the
therapist
Verbal psychodynamic
psychotherapy
aN reported is different in final sample results
bIn this trial art therapy was designated the control arm with the two garden walking formats being designated as the interventions
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Thyme [14]). The control groups across these three
studies were: CBT; garden walking; and verbal psycho-
dynamic psychotherapy respectively. In six studies art
therapy was significantly better than the control group
for some but not all outcome measures. Table 5 shows
the results according to the mean change from baseline
between groups in these six studies.
In one study (Kim [15]) outcomes for the art therapy
intervention group were significantly better than the
control group for all outcomes. Table 6 shows the results
from the Kim 2013 study [15].
In one study (Rusted [20]) from a sample of people
with dementia, outcomes were worse for the art therapy
group than the control group, which was an activity con-
trol group. An unusual pattern of results is presented
including a significant increase reported in anxious/
depressed mood (p < 0.01) at 40 weeks which is not
present at the 10 or 20 week time points and dissipates
by 44 and 56 weeks. The authors discuss several reasons
for this result including the high level of attrition; the re-
liance on observer ratings in the frail and elderly sample
Fig. 3 The eleven comparator arms from the included studies of
group art therapy
Table 3 Outcomes investigated in the eleven included studies
Study author & year Outcome domains
investigated
Outcome measures Time points
Beebe 2010 [29] Quality of life; behavioural &
emotional adaptation
Paediatric Quality of Life (PedsQL) Asthma module Beck
Youth Inventories–Second Edition
7 weeks & 6 months
Broome 2001 [13] Coping and health care
utilisation
Schoolagers Coping Strategies Inventory (SCSI)
Adolescent Coping Orientation for Problem Experiences
(A-COPE) ER visits; clinic visits; hospital admissions
4 weeks & 12 months
Gussak 2007 [30] Depression Beck Depression Inventory-Short Form (BDI) Exact time point NR “Post test”
Hattori 2011 [24] Mood; vitality; behavioural
impairment; QoL; activities of
daily living (ADL); cognitive
function
Mini-Mental State Examination Score (MMSE) Wechler
Memory Scale revised (WMS-R) Geriatric Depression Scale
(GDS); Apathy Scale (Japanese version) SF-8–Physical
(PCS-8)& Mental (MCS-8) components Barthel Index
Dementia Behaviour Disturbance Scale (DBD) Zarit
Caregiver Burden Interview
12 weeks
Kim 2013 [15] Positive/negative affect;
state-trait anxiety; self-esteem
Positive & Negative Affect Schedule (PANAS) State-Trait
Anxiety Inventory (STAI) Rosenberg Self = Esteem
Scale (RSES)
NR: assume 4 weeks
Lyshak-Stelzer 2007 [18] PTSD symptoms UCLA PTSD Reaction Index for DSM-IV Child Version
Milieu behavioural measures e.g. use of restraints
NR: reports (n)s for 2 years.
Study is ongoing in a further
15 patients
McCaffrey et al. 2011 [19] Depression Geriatric Depression Scale (GDS) 6 weeks
Monti 2006 [16] Symptoms of distress
including depression, anxiety
and quality of life
Symptom Checklist 90 Revised (SCL-90-R) Global
Severity Index (GSI) Medical Outcomes Study
Short-Form Health Survey (SF-36)
8 & 16 weeks
Monti 2012 [17] Correlation of CBF on fMRI
with experimental condition
fMRI Cerebral blood flow (CBF) and correlation with
anxiety using Symptom Checklist-90-Revised (SCL-90-R)
Within 2 weeks of end of
8-week programme
Rusted 2006 [20] Depression; mood; sociability
and physical involvement
Cornell Scale for Depression in Dementia (CSDD) The
Multi Observational Scale for the Elderly (MOSES)
The Mini-Mental State Exam (MMSE) The Rivermead
Behavioural Memory Test (RBMIT) Tests of Everyday
Attention (TEA) Benton Fluency Task
10; 20 & 40 weeks during trial
then 44 & 56 week follow up
Thyme 2007 [14] Stress reactions after a range
of traumatic events; Mental
health symptoms; Depression
Impact of Event Scale (IES) Symptom Check List
(SCL-90) Beck Depression Inventory (BDI) Hamilton
Rating Scale of Depression (HRSD)
10 weeks & 3 month follow up
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(and subsequent potential impact of observer bias); the
increased depression as a response to the sessions end-
ing; and the possibility that this sample were contra-
indicated for art therapy.
Adverse events were not reported in any of the in-
cluded RCTs. The lack of adverse event data in the ma-
jority of included studies is not necessarily evidence that
there were no adverse events in the included trials, it
may only be an indication that adverse events were not
recorded. Potential harms and negative effects of art
therapy are further explored in the qualitative review
within the full health technology assessment (Uttley et
al. (in press)).
Quality assessment of the 11 included RCTs indicated
that the trials were generally of low quality (see Table 7).
All trials had high or unclear risk of bias across several
domains particularly for: method of randomisation; allo-
cation concealment; blinding; detection bias; and incom-
plete outcome data.
In addition, withdrawals were not consistently re-
ported or accounted for in the included trials which are
particularly important considering the small sample sizes
in the included trials. Therefore attrition in the studies
represents an important confounder. Also concomitant
treatment and treatment fidelity which were rarely re-
ported, represent additional possible confounders to the
review findings.
Cost-effectiveness results and discussion
During the clinical effectiveness review 192 abstracts
were identified that were potentially relevant for cost-
effectiveness purposes and these were reviewed by a
health economic modeller. Twenty six articles were
retrieved for detailed inspection, although only 1 was
deemed relevant (12 were not art therapy; 9 contained
no economic data; 4 non-English text).
No existing models of art therapy were identified. One
paper that was deemed as potentially relevant was not
an economic appraisal but did report costs incurred and
health related benefits pertaining to a single patient over
a 6 year period [21]. This patient was one of 357 patients
initially recruited but the paper did not discuss the po-
tential impact of selection bias on the results presented.
To follow recommended National Institute of Health
and Care Excellence (NICE) guidelines [22] for conduct-
ing economic evaluations the health of patients should use
a preference based utility measure. Utility is a measure of
patient health where 0 equates to death and 1 equates to
perfect health. The Euroqol 5 dimensions (EQ-5D) is the
preferred measure by NICE. None of the RCTs identified
included a preference-based utility measure and therefore
mappings from outcome measures reported in the RCTs
to the EQ-5D were sought from an online database
(http://www.hqlo.com/content/11/1/151) reported by Dakin
[23]. Two outcome measures in the RCTs could be
mapped onto the EQ-5D: the medical outcomes short
form (36) health survey (SF-36) reported in Monti et al.
[16] and the Barthel Index reported in Hattori et al. [24].
However, in Hattori et al. [24] the Barthel index is re-
ported for the overall score only whereas mapping to the
EQ-5D would require the individual component scores.
The authors were contacted to enquire whether the indi-
vidual component data could be obtained, however, the
authors declined to provide these data due to their
intention to publish these in a forthcoming publication.
In the Monti et al. RCT all participants had a diagnosis
of breast cancer, with participants between 4 months
and 2 years post-diagnosis. Women with a terminal diag-
nosis, or who had a current diagnosis of a major mood
disorder, psychotic disorder or significant cognitive def-
icit were excluded. Those receiving any type of mental
health care could be included but had to obtain written
permission from their treating health professional to
enter the study. Eight week data from Monti et al. were
available and the SF-36 data reported are shown in
Table 8. Only those variables that have been used in the
mapping algorithms have been reported.
Two mapping algorithms from SF-36 to EQ-5D were
identified: one by Ara and Brazier [25] and one by
Rowen et al. [26], these predicted utility gains at the end
of the 8-week period of 0.0780 and 0.0871 respectively
using the data in Table 8. As the Monti et al. RCT also re-
ported changes in the Global Severity Index (GSI) [27],
the summary score from the Symptoms Checklist Revised
measure, an inference could be made between a unit
Table 4 Summary of the direction of findings from the eleven
included studies
Direction of significant findings Number Studies
Significant positive effects in all
outcome measurements
investigated in the art therapy
group compared to the control
group
1 Kim 2013 [15]
Significant positive effects in
some, but not all, outcome
measurements investigated in
the art therapy group compared
to the control group.
6 Beebe 2010 [29]
Gussak 2007 [30]
Hattori 2011a [24]
Lyshak-Stelzer 2007 [18]
Monti 2006 [16]
Monti 2012 [17]
Improvement from baseline but
no significant difference between
groups
3 Broome 2001 [13]
McCaffrey 2011 [19]
Thyme 2007 [14]
Art therapy worse than
comparator at baseline and
follow-up
1 Rusted 2006 [20]
aReported a significant positive effect for control group on one
outcome measurement
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decrease in GSI and utility gain estimated via mapping:
this value was 0.487 using the Ara and Brazier [25] map-
ping and 0.542 using the Rowen et al. [26] mapping. As
GSI data were presented in Thyme et al. [14] this trial
could now be used in an economic evaluation, albeit with
more uncertainty in the generated results. It was estimated
that at the end of the 10-week treatment period in Thyme
et al. [14] there was a utility loss associated with short-
term psychodynamic art therapy compared with short-
term psychodynamic verbal therapy, henceforth, abbrevi-
ated to verbal therapy. This value was 0.122 using the Ara
and Brazier [25] algorithm and 0125 using the Rowen et
al. [26] algorithm.
Attempts were made to make further inferences on
utility changes from the changes in the remaining out-
come measures reported in the Thyme et al. [14] RCT in
order to widen the number of RCTs considered but
Table 5 Six included studies with statistically significant findings
in the art therapy group in some but not all outcome measures
Study & control
description
Outcome measures: mean changes from
baseline (CFB) and p values
Beebe 2010 [29] Paediatric Quality of Life (PedsQL) Asthma module
Wait list Intervention positive reduction in 4/10 QoL
items at 7 weeks:
Between groups means at 7 weeks
QoL–Parent total (6.167 vs −13.091) p = 0.025;
QoL–Child total (9.727 vs −13.364) p = 0.0123;
QoL–Parent worry (47.917 vs −13.182) p = 0.0144;
QoL–Child worry (54.545 vs −45.909) p = 0.0142
Intervention positive reduction in 2/10 at
6 months:
Between groups means at 6 months:
QoL–Parent worry (58.333 vs −40.909) p = 0.024;
QoL–Child worry (79.545 vs −25.000) p = 0.0279
Beck Youth Inventories–Second Edition
Intervention significant reduction in 2/5 items at
7 weeks compared to control:
Beck–Anxiety (−15.6 vs 5.3) p = 0.0388; Beck–
Self-
concept (12.091 vs −3.545) p = 0.0222
Intervention significant reduction 1/5 at
6 months:
Beck–Anxiety (−14 vs 0.545) p = 0.03
No significant differences for depression
component of Beck youth inventory at
7 weeks (p = 0.21) or 6 months (p = 0.29)
Baseline means NR
Gussak 2007 [30] Beck Depression Inventory-Short Form (BDI)
Treatment as usual Statistically significantly greater decrease in
intervention compared to control:
BDI Intervention mean CFB (−7.81) vs
Control (+1.0) p < 0.05
Hattori 2011 [24] SF-8–Physical (PCS-8) & Mental (MCS-8)
Simple calculations Intervention significant improvement from
baseline in MCS-8 subscale of SF-8 components:
Percentage of patients showing a 10 % >
improvement was compared between groups by
chi-squared test. MCS-8 (p= 0.038; odds ratio, 5.54)
Apathy Scale (Japanese version)
Statistically significant improvement from
baseline (p = 0.0014) in Apathy scale but not
significantly different to control:
CFB Intervention (−3.2) vs Control (−1.1) p = 0.09
Mini-Mental State Examination Score (MMSE)
Control group significant improvement in
MMSE compared to art therapy intervention:
CFB Intervention (−0.02) vs Control (+1.1) p < 0.01
Wechler Memory Scale revised (WMS-R);
Geriatric Depression Scale (GDS) Barthel Index;
Dementia Behaviour Disturbance Scale (DBD);
Zarit Caregiver Burden Interview
No significant differences in other items
Table 5 Six included studies with statistically significant findings
in the art therapy group in some but not all outcome measures
(Continued)
Lyshak-Stelzer 2007 [18] UCLA PTSD Reaction Index for DSM-IV Child
Version
Arts and craft Intervention significantly better at reducing
trauma symptoms than Control:
CFB Int (−20.8) vs Con (−2.5) p < 0.01
Milieu behavioural measures e.g. use of
restraints
No significant differences for behavioural milieu
Monti 2006 [16] Global Severity Index (GSI)
Wait-list Intervention had significantly decreased symptoms
of distress and highly significant improvements in
some QoL areas: compared to control: GSI CFB Int
(−0.20) vs Con (−0.04) p < 0.001
Symptom Checklist 90 Revised (SCL-90-R)
SCL-90-R CFB: Anxiety Int (−0.26) vs Con (−0.10)
p = 0.02; Depression Int (−0.27) vs Con (−0.08)
p = 0.01
Medical Outcomes Study Short-Form Health
Survey (SF-36)
SF36: General health Int (7.97) vs Con (−.59)
p = 0.008; Mental health Int (13.05) vs Con (2.16)
p < 0.001
Monti 2012 [17] Symptom Checklist-90-Revised (SCL-90-R)
Educational support
group
Anxiety reduced in Int but not control group:
SCL-90-R decrease in Int (p = 0.03) but not in
Con (p = 0.09)
fMRI Cerebral blood flow (CBF) and correlation
with anxiety using CBF
fMRI changed in certain brain areas in art
therapy group only.
No changes in control group
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this did not allow the inclusion of further RCTs in the
economic evaluation.
Due to heterogeneity the two RCTs were analysed
separately. Based on clinical advice regarding the gener-
alisability of the RCTs to practice in England and Wales
and limitations of the Thyme et al. [14] RCT (see later)
the results from the Monti et al. [16] RCT was set to be
the primary analyses with results from Thyme et al. [14]
denoted exploratory analyses.
Within the Monti et al. RCT the costs of art therapy
per woman was assumed to be £180 using data from the
British Association of Art Therapists (BAAT) (personal
communication Val Huet, British Association of Art
Therapists, February 2014) and £248 using data reported
by Curtis [28]. For Thyme et al. the cost per participant
was £80 (BAAT) and £110 (Curtis [28]). The cost of the
verbal therapy in Thyme et al. [14] was estimated to be
£64 (BAAT) and £88 (Curtis [28]) per participant, as-
suming a verbal therapist had the same cost as an art
therapist. It was assumed that control/waitlist incurred
no cost in therapist time. Full details on the methods for
estimating costs are provided in Uttley et al. (in press).
Probabilistic sensitivity analyses were undertaken to
generate the expected cost per QALY for each RCT
using the distributions reported in Table 9. It was
assumed that all distributions were independent. Scenario
analyses were undertaken using: the Ara and Brazier [25]
and Rowen et al. [26] mapping algorithms; the BAAT and
Curtis [28] cost estimations; and 52 and 104 week residual
benefits.
In addition, a threshold analysis was conducted to as-
certain the likely level of gain in utility at 52 weeks that
would be required for art therapy, as typically used in
England and Wales, to be deemed cost effective com-
pared with wait list. This used £20,000 per QALY gained,
which is a threshold cited by NICE [22] as signifying an
intervention is likely to be cost effective. To undertake
this analysis assumptions regarding the likely cost, and
likely durations of treatment and residual benefit were
required. Whilst it is acknowledged that there is a spec-
trum of needs and treatments it was believed that the
majority of patients would be treated in either an art
therapy outpatient group or a community recovery set-
ting, with only a small proportion needing more expen-
sive treatment. Using data provided from the BAAT, it
was assumed that typical treatment would be of 42 ses-
sions, over a 52-week period and with a cost, per patient,
of £750.
Primary results from the model
Monti et al. (2006) [16] Probabilistic results for the
Monti et al. RCT are shown in Table 10. It is seen that
even in unfavourable scenarios (low residual benefit and
increased cost per participant and using the Ara and
Table 6 One included study with statistically positive findings
for all outcomes in the art therapy group
Study & control description Outcome measures and results
Kim 2013 [15] Significant improvements for Intervention in
all three outcomes compared to Control
Regular programme
activities
Positive & Negative Affect Schedule (PANAS)
PANAS CFB Intervention (19.88) vs Control
(−5.64) p < 0.01
State-Trait Anxiety Inventory (STAI)
CFB STAI State (−13.17) vs (+3.08) p < 0.01
CFB STAI Trait (−7.84) vs (+2.96) p < 0.01
Rosenberg Self = Esteem Scale (RSES)
CFB RSES (4.24) vs (−0.48) p < 0.01
Table 7 Summary of risk of bias (high, low or unclear) in the 11 included quantitative studies
Study Sequence
generation
Treatment
allocation
concealment
Performance
bias
(participant
blind)
Detection
bias (outcome
assessment
blind)
Baseline
comparability
Groups
treated
equally
Selective
outcome
reporting
Incomplete
outcome
data
Researcher
allegiance
Beebe 2010 [29] Unclear Unclear High Low Unclear High Low Unclear Low
Broome 2001 [13] Unclear Unclear High Unclear Unclear Low Low Unclear Low
Gussak 2007 [30] Unclear Unclear High Unclear High High Low Unclear High
Hattori 2011 [24] Unclear Unclear High Unclear Low Low Low Low Low
Kim 2013 [15] Unclear Unclear High High Low Low Low Low High
Lyshak-Stelzer 2007
[18]
Unclear Unclear High Unclear Low Low Low High Low
McCaffrey 2011 [19] Low Unclear High Unclear Low Low Low Low High
Monti 2006 [16] Unclear Unclear High Unclear High High Low Low Low
Monti 2012 [17] Unclear Unclear High Unclear Low Low Low High Low
Rusted 2006 [20] Unclear Unclear High Unclear High Low Low High Low
Thyme 2007 [14] Low Low High Unclear Unclear Low Low Low Low
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Brazier [25] algorithm) the expected cost per QALY is
below £6000. A histogram of the QALY benefit asso-
ciated with art therapy is shown in Fig. 4.
Threshold analysis In the threshold analysis it was cal-
culated that even with unfavourable assumptions regard-
ing length of residual benefit and mapping algorithm the
utility gain required to be cost effective would be below
0.04. This value is below that reported by Monti et al.
[16], which had a mean value of 0.078 indicating that art
therapy as practiced in England and Wales was likely to
be seen as cost effective compared with wait list.
Exploratory results from the model
Thyme et al. (2007) [14] Probabilistic results when
using data from the Thyme et al. [14] RCT are shown in
Table 11. It is seen that the expectation is that verbal
therapy dominates art therapy as it is marginally cheaper
and more efficacious. However, there is considerable un-
certainty and the 95 % confidence intervals indicate that
art therapy may have a cost per QALY gained compared
with verbal therapy of less than £300. A histogram of the
incremental benefit of verbal therapy compared with art
therapy is shown in Fig. 5: this shows considerable un-
certainty in the most effective intervention with the solid
blue bars indicating verbal therapy is more cost effective
and the striped red bars indicating that art therapy is
more cost effective. Art therapy is the more efficacious
intervention in approximately 20 % of simulations.
Evidence from two RCTs has been used to generate es-
timates of cost effectiveness, although there are caveats
regarding: the mappings; the study population; small
Table 8 The SF-36 data as reported in Monti et al. [16]
SF-36 scale Wait-list control arm (n = 55) Art therapy arm (n = 56) Change over the 8-week period Difference in
change
(Art therapy–wait-
list
control) over an
8 week
period (95 % CI)
Week 0 Week 8 Week 0 Week 8 Wait-list control Art therapy
Physical functioning 64.37 64.42 58.23 65.01 0.05 6.78 6.73 (−13.8, 0.37)
Social functioning 60.04 64.91 51.22 66.60 4.87 15.38 10.51 (−20.9, −0.10)
Physical rolea 0.00 25.00 0.00 50.00 25.00 50.00 0.00
Emotional role 33.33 66.67 33.33 66.67 33.34 33.34 0.00
Mental health 64.91 67.07 56.90 69.95 2.16 13.05 10.89 (−16.8, −4.96)
Vitality 42.63 42.91 40.26 50.06 0.28 9.80 9.52 (−16.7, −2.37)
Bodily pain 58.14 58.74 54.23 60.14 0.60 5.91 5.31 (−14.1, 3.50)
General health 55.78 55.19 47.13 55.09 −0.59 7.96 8.56 (−14.8, −2.29)
aFor discussion of the inconsistency in this scale see main text
Table 9 The distributions used in the probabilistic sensitivity analyses
Mean value 2.5th percentile 97.5th percentile
Utility gain in the Monti et al. [16], RCT of art therapy compared
with wait-list controla
0.078 0.034 0.119
Utility gain in the Monti et al. [17], RCT of art therapy compared
with wait-list controlb
0.087 0.043 0.126
Relationship between one unit decrease in GSI and utility gain
(using Ara and Brazier [25])
0.485 0.212 0.744
Relationship between one unit decrease in GSI and utility gain
(using Rowen et al. [26])
0.542 0.271 0.790
GSI decrease of verbal therapy compared with art therapy in the
Thyme et al. [14], RCT.
0.235 −0.270 0.721
(Verbal therapy
more effective)
(Art therapy
more effective)
(Verbal therapy
more effective)
Derived utility gain in the Thyme et al. [14], RCT of verbal therapy
compared with art therapy (using Ara and Brazier [25])
0.114 −0.145 0.386
Derived utility gain in the Thyme et al. [14], RCT of verbal therapy
compared with art therapy (using Rowen et al. [26])
0.127 −0.160 0.426
aHaving sampled from the SF-36 dimensions and mapped to utility using the Ara and Brazier [25] algorithm
bHaving sampled from the SF-36 dimensions and mapped to utility using the Rowen et al. [26], algorithm
Uttley et al. BMC Psychiatry  (2015) 15:151 Page 10 of 13
sample sizes; and possible confounding, all of which in-
crease the uncertainty in our results.
The Monti et al. [16] RCT recruited women with
breast cancer, of varying stages, and with a range of time
since diagnosis between 4 months and 2 years and was
conducted in the USA. The generalisability of these
women to those treated with art therapy in England and
Wales is unclear. Furthermore, there may be inaccuracy
introduced by the values in Table 8. It is noted that the
data for physical role and emotional roles at week 8, are
medians (and change in the median) due to the non-
normality of the data whereas means would be prefe-
rable. There also is a discrepancy in the results for the
physical role scale, as the values reported at weeks 0 and
8 weeks indicate a change of 25 across the 8 week period
(50–25) yet the reported difference was zero. We as-
sumed that the value of zero reported for the change be-
tween art therapy and wait list is correct, which could be
unfavourable to art therapy. A further caveat regarding
the reliability of these efficacy data is that only women
with values at baseline (week 0) and at end of treatment
(week 8) were included in the analysis with no imput-
ation for missing data. There were 11 dropouts in the
art therapy arm and 7 dropouts in the control arm. If
these reported dropouts were not random but related to
lack of (perceived) efficacy then it is possible that the re-
ported results favour art therapy.
The Thyme et al. [14] study compared art therapy and
verbal therapy. The RCT was conducted in Sweden and
recruited 44 women. At recruitment, 28 (63.6 %) study
participants were diagnosed with dysthymic disorder and
16 (36.4 %) study participants had depressive symptoms
and difficulties. One participant withdrew her participa-
tion before randomisation resulting in a final study
population at randomisation of 43 women, (21 art ther-
apy; 22 verbal therapy). Of these, 39 women completed
the study (n = 18 art therapy; n = 21 verbal therapy). The
reported results are potentially confounded by
Table 10 Probabilistic results from the Monti et al. [16] scenario: art therapy versus wait list
Using the Ara and Brazier (2008) [25] mapping Using the Rowen et al. (2009) [26] mapping
Duration of
residual benefit
Costing source Inc costs (£) Inc QALY Cost per QALY (£) (95 % CI) Inc costs (£) Inc QALY Cost per QALY (£) (95 % CI)
52 weeks BAAT 180 0.0447 4031 (2628–9202) 180 0.0499 3610 (2477–7229)
52 weeks Curtis [28] 248 0.0447 5542 (3613–12,653) 248 0.0499 4963 (3405–9940)
104 weeks BAAT 180 0.0834 2159 (1408–4930) 180 0.0931 1934 (1327–3873)
104 weeks Curtis [28] 248 0.0834 2969 (1936–6779) 248 0.0931 2659 (1824–5325)
Inc Incremental
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Fig. 4 A histogram of the utility gain of art therapy compared with wait list estimated from the Monti et al. [16], RCT, mapping from Ara and
Brazier [25] and assuming 52 weeks’ residual benefit and costs per patient from Curtis [28]
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concomitant treatment; two participants in the verbal
therapy intervention “accepted body awareness as an
additional treatment during psychotherapy” compared
with none in the art therapy arm. The mechanism by
which these women were offered body awareness is un-
clear. In addition, the use of anti-depressants may differ
between arms as the text is unclear: “In the AT group, one
participant were (sic) prescribed antidepressants during
therapy (n = 1) and one between termination of therapy
and the 3-month follow-up (n = 1), and in the VT group
three during therapy (n = 1) and two after (n = 2).” Data
from women who dropped out from the study (n = 2 art
therapy; n = 1 verbal therapy) or who were referred for
long-term art psychotherapy (n = 1 art therapy; n = 0 ver-
bal therapy) were not included in the analysis which may
add uncertainty to the results. It is noted that as two active
interventions were trialled no inference could be made
with respect to the relative efficacy compared with no
treatment.
Limitations of the work
This review can be considered as an evidence portfolio for
art therapy across several non-psychotic mental health
disorders but as such it suffers from substantial heterogen-
eity in the patient clinical profiles included. Focusing the
population of interest to specific health conditions or out-
come domains in future systematic reviews will increase
the precision of any resulting pooled treatment effects.
Conclusions
From the limited number of studies identified in patients
with different clinical profiles, art therapy was reported
to have statistically significant positive effects compared
with control in a number of studies. It was not possible
to produce pooled estimates of the clinical effectiveness
of group art therapy due to heterogeneity in the data.
The risk assessment of bias highlighted that the quality
of the included trials was generally low and prone to
areas of potential confounding. Subsequently the in-
ternal validity of the included studies is threatened. The
results from the clinical effectiveness review should be
interpreted with caution due to the generally low quality
of the small number of RCTs identified and the small
sample sizes involved.
It appears that art therapy is likely to be cost effective
compared to wait list. Using expected values art therapy
Table 11 Probabilistic results from the Thyme et al. [14] scenario: verbal therapy versus art therapy
Using the Ara and Brazier (2008) mapping [25] Using the Rowen et al. (2009) mapping [26]
Duration of
residual benefit
Costing Source Inc costs (£) Inc QALY Cost per QALY (£) (95 % CI) Inc costs (£) Inc QALY Cost per QALY (£) (95 % CI)
52 weeks BAAT −16 0.0675 Dominating (Dominating–183a) −16 0.0757 Dominating (Dominating–99a)
52 weeks Curtis [28] −22 0.0675 Dominating (Dominating–251a) −22 0.0757 Dominating (Dominating–136a)
104 weeks BAAT −16 0.1241 Dominating (Dominating–168a) −16 0.1391 Dominating (Dominating–91a)
104 weeks Curtis [28] −22 0.1241 Dominating (Dominating–230a) −22 0.1391 Dominating (Dominating–125a)
N.B.: Dominated means both more expensive and less efficacious
Inc Incremental
aThese values represent cost per QALY lost and as such these upper bound values indicate art therapy is more cost effective than verbal therapy
Fig. 5 A histogram of the utility gain of verbal therapy compared with art therapy estimated from the Thyme et al. [14], RCT, mapping from Ara
and Brazier [25] and assuming 52 weeks’ residual benefit and costs per patient from Curtis [28]
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appears to be dominated by verbal therapy although
there is considerable uncertainty, with art therapy being
the more cost effective treatment in approximately 20 %
of simulations. Given this, and the limitations of the evi-
dence for art therapy versus verbal therapy RCT, no de-
finitive statement can be made regarding this
comparison.
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